vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $26.2M, roughly 1.7× BCB BANCORP INC). BCB BANCORP INC runs the higher net margin — -49.7% vs -227.5%, a 177.8% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 13.1%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 1.8%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
BCBP vs GRAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $43.6M |
| Net Profit | $-12.0M | $-99.2M |
| Gross Margin | — | — |
| Operating Margin | -71.9% | -285.4% |
| Net Margin | -49.7% | -227.5% |
| Revenue YoY | 13.1% | 14.0% |
| Net Profit YoY | -467.6% | -2.2% |
| EPS (diluted) | $-0.73 | $-2.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $43.6M | ||
| Q3 25 | $26.5M | $36.2M | ||
| Q2 25 | $25.2M | $35.5M | ||
| Q1 25 | $23.8M | $31.8M | ||
| Q4 24 | $23.1M | $38.3M | ||
| Q3 24 | $26.2M | $28.7M | ||
| Q2 24 | $20.4M | $32.0M | ||
| Q1 24 | $25.3M | $26.7M |
| Q4 25 | $-12.0M | $-99.2M | ||
| Q3 25 | $4.3M | $-89.0M | ||
| Q2 25 | $3.6M | $-114.0M | ||
| Q1 25 | $-8.3M | $-106.2M | ||
| Q4 24 | $3.3M | $-97.1M | ||
| Q3 24 | $6.7M | $-125.7M | ||
| Q2 24 | $2.8M | $-1.6B | ||
| Q1 24 | $5.9M | $-218.9M |
| Q4 25 | -71.9% | -285.4% | ||
| Q3 25 | 21.9% | -346.2% | ||
| Q2 25 | 19.9% | -446.9% | ||
| Q1 25 | -49.2% | -482.5% | ||
| Q4 24 | 19.9% | -358.0% | ||
| Q3 24 | 35.7% | -640.5% | ||
| Q2 24 | 19.5% | -5133.8% | ||
| Q1 24 | 33.0% | -851.1% |
| Q4 25 | -49.7% | -227.5% | ||
| Q3 25 | 16.1% | -245.8% | ||
| Q2 25 | 14.2% | -320.7% | ||
| Q1 25 | -35.0% | -333.6% | ||
| Q4 24 | 14.1% | -253.8% | ||
| Q3 24 | 25.5% | -438.7% | ||
| Q2 24 | 13.8% | -4958.8% | ||
| Q1 24 | 23.2% | -819.3% |
| Q4 25 | $-0.73 | $-2.37 | ||
| Q3 25 | $0.22 | $-2.46 | ||
| Q2 25 | $0.18 | $-3.18 | ||
| Q1 25 | $-0.51 | $-3.10 | ||
| Q4 24 | $0.17 | $-1.49 | ||
| Q3 24 | $0.36 | $-3.94 | ||
| Q2 24 | $0.14 | $-51.06 | ||
| Q1 24 | $0.32 | $-7.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $249.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.3M | $2.6B |
| Total Assets | $3.3B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $249.7M | ||
| Q3 25 | — | $126.9M | ||
| Q2 25 | — | $127.4M | ||
| Q1 25 | — | $133.9M | ||
| Q4 24 | — | $214.2M | ||
| Q3 24 | — | $853.6M | ||
| Q2 24 | — | $958.8M | ||
| Q1 24 | — | $199.7M |
| Q4 25 | $304.3M | $2.6B | ||
| Q3 25 | $318.5M | $2.2B | ||
| Q2 25 | $315.7M | $2.3B | ||
| Q1 25 | $314.7M | $2.4B | ||
| Q4 24 | $323.9M | $2.5B | ||
| Q3 24 | $328.1M | $2.6B | ||
| Q2 24 | $320.7M | $2.7B | ||
| Q1 24 | $320.1M | — |
| Q4 25 | $3.3B | $2.9B | ||
| Q3 25 | $3.4B | $2.6B | ||
| Q2 25 | $3.4B | $2.7B | ||
| Q1 25 | $3.5B | $2.8B | ||
| Q4 24 | $3.6B | $3.0B | ||
| Q3 24 | $3.6B | $3.1B | ||
| Q2 24 | $3.8B | $3.3B | ||
| Q1 24 | $3.8B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $-63.8M |
| Free Cash FlowOCF − Capex | $34.9M | $-63.9M |
| FCF MarginFCF / Revenue | 133.3% | -146.5% |
| Capex IntensityCapex / Revenue | 4.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $-299.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $-63.8M | ||
| Q3 25 | $8.7M | $-63.2M | ||
| Q2 25 | $10.3M | $-77.0M | ||
| Q1 25 | $5.0M | $-95.0M | ||
| Q4 24 | $67.7M | — | ||
| Q3 24 | $43.5M | $-104.6M | ||
| Q2 24 | $8.1M | $-171.8M | ||
| Q1 24 | $8.3M | $-207.3M |
| Q4 25 | $34.9M | $-63.9M | ||
| Q3 25 | $8.5M | $-63.6M | ||
| Q2 25 | $10.2M | $-77.3M | ||
| Q1 25 | $4.7M | $-95.1M | ||
| Q4 24 | $66.5M | — | ||
| Q3 24 | $43.4M | $-105.6M | ||
| Q2 24 | $8.1M | $-173.2M | ||
| Q1 24 | $8.1M | $-209.8M |
| Q4 25 | 133.3% | -146.5% | ||
| Q3 25 | 32.0% | -175.8% | ||
| Q2 25 | 40.4% | -217.6% | ||
| Q1 25 | 19.8% | -298.6% | ||
| Q4 24 | 287.5% | — | ||
| Q3 24 | 166.0% | -368.4% | ||
| Q2 24 | 39.6% | -541.7% | ||
| Q1 24 | 32.3% | -785.3% |
| Q4 25 | 4.0% | 0.2% | ||
| Q3 25 | 1.1% | 1.1% | ||
| Q2 25 | 0.6% | 1.0% | ||
| Q1 25 | 1.2% | 0.2% | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 0.3% | 3.4% | ||
| Q2 24 | 0.2% | 4.3% | ||
| Q1 24 | 0.6% | 9.5% |
| Q4 25 | — | — | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 2.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.70× | — | ||
| Q3 24 | 6.53× | — | ||
| Q2 24 | 2.88× | — | ||
| Q1 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCBP
Segment breakdown not available.
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
